Anthropic PBC is widely releasing a version of Mythos that will be blocked from carrying out cybersecurity tasks, months after warning that the powerful artificial intelligence model could spot and ...
In randomized trials, finerenone, a nonsteroidal mineralocorticoid receptor antagonist, improved kidney and cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease (CKD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results